Target intelligence / Profile preview

Kinetochore protein NDC80 homolog (HEC1) (HEC1)

Target
HEC1
Molecular classification
Kinetochore protein, Microtubule-binding protein, NDC80 complex subunit
01

Overview

Kinetochore protein Hec1 (Highly Expressed in Cancer 1), also known as NDC80, is a fundamental component of the outer kinetochore NDC80 complex, which mediates the essential connection between chromosomes and spindle microtubules during mitosis [1][2]. It is critical for maintaining the stability of kinetochore-microtubule attachments and for the proper functioning of the spindle assembly checkpoint, which prevents premature chromosome segregation [3]. Hec1 is frequently overexpressed in numerous malignancies, including breast, lung, and colorectal cancers, where its upregulation is associated with chromosomal instability and poor clinical outcomes [4][5]. Due to its indispensable role in the division of cancer cells and its relatively low expression in quiescent normal cells, Hec1 is a high-priority target for anti-cancer drug development [6]. Therapeutic strategies primarily involve small molecules that disrupt the interaction between Hec1 and its regulatory kinase Nek2 or inhibit Hec1's ability to bind microtubules, thereby inducing mitotic arrest and cell death [7][8]. Citations: [1] UniProt (O14777); [2] PubMed (PMID: 11724931); [3] PubMed (PMID: 12439614); [4] PubMed (PMID: 19343110); [5] PubMed (PMID: 23536446); [6] PubMed (PMID: 21813410); [7] PubMed (PMID: 26452218); [8] PubMed (PMID: 18483225).

Other names
Highly expressed in cancer proteinNDC80KNTC2HECTID3Kinetochore protein Hec1
02

Mechanism of action

Inhibition of the Hec1-Nek2 protein-protein interaction or disruption of Hec1-microtubule binding, leading to mitotic arrest, chromosomal instability, and subsequent apoptosis.

03

Biological functions

Cell cycleMitosisChromosome segregationSpindle assembly checkpointMicrotubule attachment
04

Disease associations

CancerBreast cancerLung cancerLiver cancerColorectal cancerGlioblastoma
05

Safety considerations

Potential for myelosuppressionGastrointestinal toxicityGeneral mitotic inhibitor side effectsRisk of chromosomal instability in non-target cells
06

Interacting drugs

TAI-1

3 more in the full profile.

07

Biomarkers

Hec1 protein overexpressionHEC1 mRNA levelsNek2 expression levels

Beyond the preview

Go deeper on Kinetochore protein NDC80 homolog (HEC1) (HEC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinetochore protein NDC80 homolog (HEC1) (HEC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call